Literature DB >> 33433914

Total Synthesis of Tiacumicin B: Study of the Challenging β-Selective Glycosylations*.

Cédric Tresse1, Marc François-Heude1, Vincent Servajean1, Rubal Ravinder1, Clémence Lesieur1, Lucie Geiben1, Louis Jeanne-Julien2, Vincent Steinmetz1, Pascal Retailleau1, Emmanuel Roulland2, Jean-Marie Beau1,3, Stéphanie Norsikian1.   

Abstract

We give a full account of the total synthesis of tiacumicin B (Tcn-B), a natural glycosylated macrolide with remarkable antibiotic properties. Our strategy is based on our experience with the synthesis of the tiacumicin B aglycone and on unique 1,2-cis-glycosylation steps. We used sulfoxide anomeric leaving-groups in combination with a remote 3-O-picoloyl group on the donors that allowed highly β-selective rhamnosylation and noviosylation that rely on H-bond-mediated aglycone delivery. The rhamnosylated C1-C3 fragment was anchored to the C4-C19 aglycone fragment by a Suzuki-Miyaura cross-coupling. Ring-size-selective Shiina macrolactonization provided a semiglycosylated aglycone that was engaged directly in the noviolysation step with a virtually total β-selectivity. Finally, a novel deprotection method was devised for the removal of a 2-naphthylmethyl ether on a phenol, and efficient removal of all the protecting groups provided synthetic tiacumicin B.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  antibiotics; cis-glycosylation; glycochemistry; natural products; total synthesis

Year:  2021        PMID: 33433914     DOI: 10.1002/chem.202005102

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

Review 1.  Recent advances in stereoselective 1,2-cis-O-glycosylations.

Authors:  Akihiro Ishiwata; Katsunori Tanaka; Jiaming Ao; Feiqing Ding; Yukishige Ito
Journal:  Front Chem       Date:  2022-08-19       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.